by Ernest Aguila
Rastafarians, researchers and medical marijuana users were similar
enthralled to hear the news about legalizing marijuana in Colombia.
Moreover, the news of his medical use also reveal how a derivative of
plant chemistry can help in the fight against epilepsy, especially with the way
DEA has recently moderated in some of its regulations, according to sources.
In recent news, the president of Colombia, Juan Manuel Santos signed a
decree legalizing the sale and growth of marijuana for medical purposes,
as the country moves from drug policies supported by the United States, courtesy of The Guardian.
“The new rules represent an important step that put Colombia in the
avant-garde and the forefront of the fight against the disease “, Colombian
The president said during the signing ceremony for the country
legalization of the plant, as stated by the source.
“This decree allows licenses to be granted for possession of
seeds, cannabis plants and marijuana, “Santos, according to Yahoo News.
“The manufacture, export, sale and use of medical and scientific
this and other substances has been allowed for decades in
Colombia. “Our goal is that patients have access to medicines produced in
Colombia, which are safe and of high quality, and accessible. It is also a
opportunity to promote scientific research in our country, “plus
Moreover, the news has revealed that a team of doctors could have
possibly discovered the key to combating epilepsy in a one-year study
He showed the effectiveness of cannabidiol (CBD), a derivative of the doctor
marijuana without psychoactive properties, management
the refractory epilepsy in children and adults, as reported by microphone technology.
“We are very encouraged by our test results show that the CBD was
safe and well tolerated for most patients, and reduced seizures
significantly, “lead researcher Orrin Devinsky said in a statement,
courtesy of the source.
Dr. Scott Stevens said the news of medical use of marijuana in the treatment of epilepsy is only the first step, as declared by the US News Health.
“The results of this study highlight as a step towards greater
Studies evaluating the use of marijuana in the treatment of epilepsy, ”
In addition, the US Drug Enforcement Agency (DEA) has decided
loosen some of its regulatory policies imposed on those who were
Performing FDA approved clinical trials in cannabidiol (CBD) and
reported by Forbes.
“This is certainly a step in the right direction towards
development and testing of the CBD as an effective compound empirically, “ Kalytera CEO Seth Yakatan said, courtesy of the source.
“Marijuana Legalization in Colombia announced; DEA war! ” is replublished article http://thefutureofcannabisintheworld.blogspot.com/2015/12/marijuana-legalization-in-colombia.html